Taï Forest ebolavirus

Taï Forest ebolavirus (TAFV), also known as Côte d'Ivoire ebolavirus, is one of the six species of Ebola virus identified to date. It is named after the Taï Forest in Côte d'Ivoire (Ivory Coast), where the virus was first discovered. Unlike its more notorious cousin, the Zaire ebolavirus, which is responsible for the largest Ebola outbreaks in history, Taï Forest ebolavirus has been identified in a single human case as well as in several non-human primates.

Discovery

The virus was first identified in 1994 when a female ethologist contracted the virus after performing a necropsy on a chimpanzee found dead in the Taï Forest. The chimpanzee was later confirmed to have died from Taï Forest ebolavirus infection. The ethologist developed symptoms similar to those caused by other Ebola viruses but recovered, marking the first known human infection and survival from Taï Forest ebolavirus.

Virology

Taï Forest ebolavirus is a filovirus, a category that also includes the Ebola and Marburg viruses. Filoviruses are characterized by their filamentous structure visible under an electron microscope. The genome of Taï Forest ebolavirus is a single-stranded RNA approximately 19 kilobases in length, encoding seven structural and regulatory proteins.

Epidemiology

The natural reservoir of Taï Forest ebolavirus remains unidentified, although bats are considered the most likely candidates, similar to other Ebola viruses. The virus's transmission to humans is believed to occur through contact with infected animals or their bodily fluids. The single documented case of human infection suggests that while Taï Forest ebolavirus can cause disease in humans, its potential for human-to-human transmission appears limited compared to other Ebola virus species.

Clinical Presentation

The clinical presentation of Taï Forest ebolavirus infection in humans is similar to that of other Ebola viruses, characterized by the sudden onset of fever, fatigue, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, and in some cases, internal and external bleeding. However, the single documented case of Taï Forest ebolavirus infection was less severe and resulted in recovery, suggesting possible differences in virulence between Ebola virus species.

Prevention and Control

Due to the limited number of cases, specific guidelines for the prevention and control of Taï Forest ebolavirus are not well-established. However, general measures for controlling Ebola virus disease, such as avoiding contact with infected animals, wearing protective clothing, and practicing good hygiene, are recommended. In the absence of a specific vaccine or treatment for Taï Forest ebolavirus, supportive care and treatment of symptoms are the mainstay of management for infected individuals.

Research and Future Directions

Research on Taï Forest ebolavirus is ongoing, with efforts focused on understanding its ecology, reservoir hosts, and potential for human transmission. The development of diagnostic tools, vaccines, and therapeutics specific to Taï Forest ebolavirus is also a priority, given the potential for future spillover events and the need for preparedness.

‎